Quarterly report · Q2

Period2022-12-01 → 2023-05-31
Filed2023-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-12-01 → 2022-05-31Cons.Net sales
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Operating income¥226m2021-12-01 → 2022-05-31Cons.Operating income
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥235m2021-12-01 → 2022-05-31Cons.Ordinary income
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥234m2021-12-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥179m2021-12-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Net income¥179m2021-12-01 → 2022-05-31Cons.Profit loss
Total assets¥8.0bnat 2023-05-31Cons.Assets
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.8bnat 2022-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.5bnat 2023-05-31Cons.Liabilities
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.4bnat 2022-05-31Cons.Net assets (5-year summary)
Cash and deposits¥999mat 2023-05-31Cons.Cash and deposits
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥984mat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30dCons.Cash and cash equivalents
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥21m2021-12-01 → 2022-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥124m2021-12-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥243m2021-12-01 → 2022-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥121m2021-12-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥162m2021-12-01 → 2022-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥104m2021-12-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.062021-12-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.822022-03-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio30.6%at 2022-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-05-31¥211m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-05-31¥226m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 469
ItemContextValueUnit
Increase decrease in provision for directors retirement benefits ope cfPrior1YTDDuration-29150000JPY
Increase decrease in provision for directors retirement benefits ope cfCurrentYTDDuration-26325000JPY
Interest and dividends income ope cfPrior1YTDDuration-2281000JPY
Interest and dividends income ope cfCurrentYTDDuration-2588000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-100000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration678000JPY
Interest expenses paid on loans and bonds ope cfPrior1YTDDuration8797000JPY
Interest expenses paid on loans and bonds ope cfCurrentYTDDuration8868000JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration1736000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration1064000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration52371000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration193667000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-372913000JPY
Decrease increase in inventories ope cfCurrentYTDDuration150108000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration28004000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-340818000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration-38468000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration67192000JPY
Other net ope cfPrior1YTDDuration-101200000JPY
Other net ope cfCurrentYTDDuration-120768000JPY
Subtotal ope cfPrior1YTDDuration-38207000JPY
Subtotal ope cfCurrentYTDDuration251448000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration2281000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration2588000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-8773000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-8811000JPY
Income taxes paid ope cfPrior1YTDDuration-79585000JPY
Income taxes paid ope cfCurrentYTDDuration-22027000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-124285000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration223197000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-122749000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-220908000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-1800000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration3929000JPY
Other net inv cfCurrentYTDDuration3893000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-120620000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-217015000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration-JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration200000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-36658000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-50796000JPY
Repayments of lease obligations fin cfPrior1YTDDuration-6910000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-8861000JPY
Cash dividends paid fin cfPrior1YTDDuration-60587000JPY
Cash dividends paid fin cfCurrentYTDDuration-60513000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-104155000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration79828000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration13416000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration2411000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-05-31pass